B

Balaxi Pharmaceuticals Ltd
NSE:BALAXI

Watchlist Manager
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
Watchlist
Price: 21.12 INR 12.34% Market Closed
Market Cap: ₹1.2B

Profitability Summary

Balaxi Pharmaceuticals Ltd's profitability score is 37/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

37 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

37 / 100
Profitability
Score
37 / 100
Profitability
Score

Margins

Earnings Waterfall
Balaxi Pharmaceuticals Ltd

Margins Comparison
Balaxi Pharmaceuticals Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
1.2B INR
Loading...
Loading...
Loading...
US
Mckesson Corp
NYSE:MCK
108.8B USD
Loading...
Loading...
Loading...
US
Cencora Inc
NYSE:COR
63.2B USD
Loading...
Loading...
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
62.4B USD
Loading...
Loading...
Loading...
US
Cardinal Health Inc
NYSE:CAH
50.5B USD
Loading...
Loading...
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
30.6B AUD
Loading...
Loading...
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
64.7B CNY
Loading...
Loading...
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.3B CNY
Loading...
Loading...
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
8.6B USD
Loading...
Loading...
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
65.3B HKD
Loading...
Loading...
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Balaxi Pharmaceuticals Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
1.2B INR
Loading...
Loading...
Loading...
Loading...
US
Mckesson Corp
NYSE:MCK
108.8B USD
Loading...
Loading...
Loading...
Loading...
US
Cencora Inc
NYSE:COR
63.2B USD
Loading...
Loading...
Loading...
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
62.4B USD
Loading...
Loading...
Loading...
Loading...
US
Cardinal Health Inc
NYSE:CAH
50.5B USD
Loading...
Loading...
Loading...
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
30.6B AUD
Loading...
Loading...
Loading...
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
64.7B CNY
Loading...
Loading...
Loading...
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.3B CNY
Loading...
Loading...
Loading...
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
8.6B USD
Loading...
Loading...
Loading...
Loading...
CN
Sinopharm Group Co Ltd
HKEX:1099
65.3B HKD
Loading...
Loading...
Loading...
Loading...
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Balaxi Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett